Cargando…

High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling

BACKGROUND: Preoperative chemoradiotherapy (pCRT) is a common and essential therapeutic strategy for patients with locally advanced rectal cancer (LARC), but poor tumor response and therapeutic resistance to chemoradiotherapy have appeared usually among persons and affected those patients' surv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hao, Zhang, Zhenzhan, Zhen, Peilin, Zhou, Meijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811563/ https://www.ncbi.nlm.nih.gov/pubmed/33506057 http://dx.doi.org/10.1155/2021/6657012

Ejemplares similares

Amplification of Adipogenic Commitment by VSTM2A
por: Secco, Blandine, et al.
Publicado: (2017)

VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6
por: Dong, Yujuan, et al.
Publicado: (2019)

VSTM1 regulates monocyte/macrophage function via the NF-κB signaling pathway
por: Wang, Xiao-Fei, et al.
Publicado: (2021)

Partial dissociation in the neural bases of VSTM and imagery in the early visual cortex
por: Saad, Elyana, et al.
Publicado: (2015)

Pan-Cancer Analysis Reveals the Multidimensional Expression and Prognostic and Immunologic Roles of VSTM2L in Cancer
por: Zhang, Shuyi, et al.
Publicado: (2022)

Metacognition of Visual Short-Term Memory: Dissociation between Objective and Subjective Components of VSTM
por: Bona, Silvia, et al.
Publicado: (2013)

Differential effects of N-linked glycosylation of Vstm5 at multiple sites on surface expression and filopodia formation
por: Lee, A-Ram, et al.
Publicado: (2017)

Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
por: Miyako, Shoji, et al.
Publicado: (2023)

VSTM1-v2 does not drive human Th17 cell differentiation: A replication study
por: von Richthofen, Helen J., et al.
Publicado: (2023)

A functional SNP associated with atopic dermatitis controls cell type-specific methylation of the VSTM1 gene locus
por: Kumar, Dilip, et al.
Publicado: (2017)

VSTM-v1, a potential myeloid differentiation antigen that is downregulated in bone marrow cells from myeloid leukemia patients
por: Xie, Min, et al.
Publicado: (2015)

Chemoradiotherapy response in recurrent rectal cancer
por: Yu, Stanley K T, et al.
Publicado: (2014)

IL-4 enhances survival of in vitro-differentiated mouse basophils through transcription-independent signaling downstream of PI3K
por: Reinhart, Ramona, et al.
Publicado: (2018)

Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity
por: Wang, Dashan, et al.
Publicado: (2016)

Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients
por: Zhang, Rong-xin, et al.
Publicado: (2017)

Timing of surgery following chemoradiotherapy in rectal Cancer
por: Brown, Gina, et al.
Publicado: (2014)

Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023)

Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling
por: Li, Yang, et al.
Publicado: (2023)

ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer
por: He, Lin, et al.
Publicado: (2021)

Metastatic role of mammalian target of rapamycin signaling activation by chemoradiotherapy in advanced rectal cancer
por: Shiratori, Hiroshi, et al.
Publicado: (2020)

Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
por: Lee, Joo Ho, et al.
Publicado: (2011)

Radiofrequency thermal treatment with chemoradiotherapy for advanced rectal cancer
por: SHOJI, HISANORI, et al.
Publicado: (2016)

A review of preoperative chemoradiotherapy for lower rectal cancer
por: Beppu, Naohito, et al.
Publicado: (2018)

HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer
por: Huang, Yi-Jung, et al.
Publicado: (2022)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

Preoperative Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer
por: De Felice, Francesca, et al.
Publicado: (2013)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Yi, et al.
Publicado: (2016)

Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer
por: Zhang, Jin-Liang, et al.
Publicado: (2017)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer
por: Sakr, Amr, et al.
Publicado: (2020)

Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients
por: Yasui, Kazuaki, et al.
Publicado: (2020)

Predictive immunohistochemical features for tumour response to chemoradiotherapy in rectal cancer
por: Shinto, E., et al.
Publicado: (2020)

Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy
por: Yang, Jie, et al.
Publicado: (2019)

Organ preservation for early rectal cancer using preoperative chemoradiotherapy
por: Son, Gyung Mo
Publicado: (2023)

Expression of TSLP and Downstream Molecules IL-4, IL-5, and IL-13 on the Eye Surface of Patients with Various Types of Allergic Conjunctivitis
por: Zheng, Xiaofen, et al.
Publicado: (2016)

Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
por: Huemer, Florian, et al.
Publicado: (2020)

Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older
por: Cai, Xin, et al.
Publicado: (2013)

Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
por: Bang, Hyun Jin, et al.
Publicado: (2023)

Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer
por: Zhang, Shu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h31teel2eib17s4vcgsah9e4ui